PubMed Health⌕ Search

Biomedical subjects

B S Roberson

Publications and source records attributed to B S Roberson.

23 records · Page 2Linked to original sources
PubMed1970

Positive fluorescent treponemal antibody reactions in diabetes.

In a survey of 129 diabetic patients and 142 normal individuals, a significantly higher percentage of positive reactions in the fluorescent treponemal antibody-200 (FTA-200) test was found among diabetic patients than in the normal population. Absorption of all FTA-200-reactive sera with an extract of Reiter's treponeme eliminated most of the positive reactions in sera from diabetic patients, and three of the five positive reactions detected in sera from apparently normal subjects. On immunoelectrophoresis, precipitin bands developed most frequently between the Reiter sorbent and sera from diabetic patients positive in the FTA-200 test. Serum components responsible for FTA reactivity and precipitin reactions against the sorbent were resistant to treatment with mercaptoethanol, suggesting antibody of the IgG class. Cross-reacting antibodies produced in response to normal treponemal flora, and perhaps acquiring enhanced reactivity by means of nonspecific interacting substances in sera peculiar to the altered physiological state of diabetes, are suggested as possible causes of positive reactions of unabsorbed sera. No correlation could be made between age of the diabetic patient, treatment or duration of the disease, and FTA or precipitin reactivity of the patient's serum.

Cross Reactions↗
PubMed1969

Association of toxic capsule and cell wall mucopeptide with virulence in Gaffkya tetragena.

Nine strains of organisms morphologically and physiologically identified as Gaffkya tetragena were obtained from various sources to study their pathogenicity. Initial virulence analysis of all strains by mouse intraperitoneal injection of viable cells revealed that only three strains, recently isolated from and associated with respiratory infections in hospitalized patients, caused death of mice within 48 hr. The ld(50) for these virulent, encapsulated strains was 1 x 10(7) to 6 x 10(7) viable organisms. To associate virulence with a toxic component, the following fractions were purified from all strains: capsular material, cell walls, mucopeptide preparations from cell walls and whole cells, grouplike material, cytoplasmic material, and culture filtrate with and without added reducing agent. Rabbit and mouse dermal toxicity testing of these fractions revealed that the capsular material, cell walls, and mucopeptide preparations of the virulent strains were toxic. None of the nonvirulent strains contained toxic components, with the exception of one strain which yielded capsular material equal in toxicity to that of the virulent strains. The capsular material induced a soft pustular lesion persisting for approximately 22 days. Cell walls and mucopeptide preparations produced a hard nodular lesion, identical to that produced by autoclaved whole cells, that persisted for 25 to 30 days. One strain may represent a virulence intermediate between the virulent and nonvirulent strains, since it contains toxic capsular material but nontoxic cell wall mucopeptide. The results indicate that the virulence of this organism is associated with toxic capsular material and cell wall mucopeptide.

Cell Wall↗
PubMedDate not supplied

Interactions between radioresistant T cells from plasmacytoma-bearing mice and radiosensitive T cells from normal mice leading to suppression.

Spleens from BALB/c mice bearing the plasmacytoma SPQC 11 contain a population of T cells capable of suppressing the production of antibodies when cultured with normal BALB/c splenocytes, but not with splenocytes from nude BALB/c mice. Inhibition was characteristically the most effective at low suppressor cell numbers using unirradiated T cells. Maximum suppression occurred when a radiosensitive population of T cells from normal mice interacted with a population of radioresistant T cells from plasmacytoma-bearing animals. Accurate characterization of the suppressor T cell activity required testing over a wide range of suppressor/indicator cell ratios. Suppressor activity was eliminated by treatment with anti-Thy 1.2 plus complement, was radioresistant and present over a full range of doses when irradiated cells were used.

Animals↗